Guidelines for Stenting vs Stone Removal in Choledocholithiasis
Primary Recommendation
Stone extraction should be offered to all patients with choledocholithiasis whenever technically possible, with biliary stenting reserved only as a temporary measure or for highly selected patients with prohibitive surgical risk and limited life expectancy. 1
Treatment Algorithm
First-Line: Complete Stone Removal
Endoscopic stone extraction via ERCP with sphincterotomy is the primary treatment approach, achieving 90% success rates in standard cases. 2, 3 The goal is complete duct clearance, not temporary drainage. 1
- For large stones (≥10mm): Endoscopic papillary large balloon dilation (EPLBD) combined with sphincterotomy facilitates removal and achieves 95.6% complete clearance rates. 1, 2, 4
- For difficult stones: Mechanical lithotripsy should be employed when standard basket/balloon extraction fails. 1
- When conventional techniques fail: Cholangioscopy-guided electrohydraulic or laser lithotripsy achieves 73-97% stone clearance rates and should be attempted before abandoning extraction efforts. 1, 2
Surgical Alternative: Laparoscopic Bile Duct Exploration (LBDE)
LBDE is equally valid to ERCP with no difference in efficacy, mortality, or morbidity, but offers shorter hospital stays (approximately 8 days faster return to work). 1, 2 This should be considered an equivalent first-line option when local expertise exists. 1
- Transcystic approach works for small stones with limited common hepatic duct access. 1
- Transductal approach allows retrieval of larger stones and better duct access. 1
- Intraductal lithotripsy (piezoelectric or laser) can increase clearance rates to near 100%. 1
Last Resort Options Before Stenting
Percutaneous radiological stone extraction and open duct exploration should be reserved for patients in whom endoscopic and laparoscopic techniques fail or are not possible. 1, 2 These are preferable to permanent stenting in patients who can tolerate intervention. 2
When Stenting Is Appropriate
Temporary Stenting (Strong Recommendation)
Short-term biliary stent placement is recommended when stones cannot be extracted during the initial procedure, followed by further endoscopy or surgery within 4-6 weeks. 1, 2 This ensures adequate biliary drainage while planning definitive treatment. 1
- Use for acute cholangitis or sepsis to stabilize patients before definitive extraction. 2
- Place when complete clearance cannot be achieved but patient can tolerate future intervention. 1
Permanent Stenting (Restricted Use)
Biliary stenting as sole treatment should be restricted to highly selected patients with limited life expectancy and/or prohibitive surgical risk. 1 This is explicitly a compromise, not standard care. 1
- Consider only when operative risk is deemed prohibitive. 1
- Recognize this leaves stones in situ with ongoing risks. 1
Critical Pitfalls to Avoid
Never proceed directly to permanent stenting without attempting advanced endoscopic techniques including EPLBD, mechanical lithotripsy, and cholangioscopy-guided lithotripsy. 2 The 6-10% complication rate of sphincterotomy is far lower than accepting untreated stone disease. 2
Do not accept incomplete stone clearance as adequate treatment in patients who can tolerate further intervention. 1 Residual stones carry risks of recurrent cholangitis, pancreatitis, and biliary obstruction. 1
Avoid using "difficult anatomy" as justification for stenting alone when percutaneous or surgical options remain available. 1 Expertise should be sought at referral centers for complex cases. 2
Special Populations
Elderly Patients (≥90 years)
ERCP with stone extraction remains safe and effective in patients ≥90 years old, with similar complication rates (9.5% vs 7.7% in younger elderly). 5 However, complete stone removal rates are lower (81.0% vs 94.9%), making permanent stenting more acceptable in this population when extraction fails. 5
Patients with Coagulopathy
EPBD without prior sphincterotomy may be considered as an alternative to sphincterotomy in patients with uncorrected coagulopathy, though this carries increased pancreatitis risk. 1 Anticoagulation should be managed per BSG/ESGE guidelines. 1
Patients with Gallbladder In Situ
After successful duct clearance, prophylactic cholecystectomy significantly reduces mortality (7.9% vs 14.1%) and recurrent biliary events over follow-up periods of 17 months to 5+ years. 1 The gallbladder should not be left in place after stone extraction unless surgical risk is prohibitive. 1